How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comFirst in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant
Description:
This is the first-in-human study of 68Ga/64Cu-FAPI-XT117, which is an prospective, single-arm phase I clinical study.
Sponsor:
Chinese PLA General Hospital
Phase:
Phase 1
Contacts:
Zhihui Shenshenzhihui301@126.com
010-66936793
Government Study Link:
NCT05814835 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience